108 related articles for article (PubMed ID: 30973108)
1. Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicity.
Singh H; Nambiar N; Samani D; Gangakhedkar RR
Curr Mol Med; 2019; 19(3):206-215. PubMed ID: 30973108
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 polymorphisms and susceptibility to ARV associated hepatotoxicity.
Singh H; Samani D; Nain S; Dhole TN
Microb Pathog; 2019 Aug; 133():103544. PubMed ID: 31121270
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of CYP2B6 516G>T polymorphism in patients with ARV-associated hepatotoxicity.
Singh H; Lata S; Dhole TN; Gangakhedkar RR
Mol Genet Genomic Med; 2019 Apr; 7(4):e00598. PubMed ID: 30864294
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of CYP2D6*4 1934G/A polymorphism in Western Indian HIV patients.
Singh H; Lata S; Gangakhedkar RR
APMIS; 2018 Nov; 126(11):842-851. PubMed ID: 30357957
[TBL] [Abstract][Full Text] [Related]
5. IL-1RN and IL-1
Singh H; Samani D; Nema V; Ghate MV; Gangakhedkar RR
Mediators Inflamm; 2018; 2018():4398150. PubMed ID: 29849489
[TBL] [Abstract][Full Text] [Related]
6. Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.
Singh HO; Lata S; Angadi M; Bapat S; Pawar J; Nema V; Ghate MV; Sahay S; Gangakhedkar RR
Pharmacogenomics J; 2017 Jan; 17(1):53-60. PubMed ID: 26667829
[TBL] [Abstract][Full Text] [Related]
7. CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity.
Singh H; Lata S; Nema V; Samani D; Ghate M; Gangakhedkar RR
APMIS; 2017 Jun; 125(6):523-535. PubMed ID: 28370504
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of ABCC3-1767G/A polymorphism among patients with antiretroviral-associated hepatotoxicity.
Singh H; Lata S; Choudhari R; Dhole TN
Mol Genet Genomic Med; 2020 Jun; 8(6):e1124. PubMed ID: 32212330
[TBL] [Abstract][Full Text] [Related]
9. Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique.
Ciccacci C; Borgiani P; Ceffa S; Sirianni E; Marazzi MC; Altan AM; Paturzo G; Bramanti P; Novelli G; Palombi L
Pharmacogenomics; 2010 Jan; 11(1):23-31. PubMed ID: 20017669
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in miRNAs Gene (146a, 149, 196a) and Susceptibility to ARV-associated Hepatotoxicity.
Singh HO; Jadhav S; Samani D; Dhole TN
Curr Genomics; 2019 Feb; 20(2):134-150. PubMed ID: 31555064
[TBL] [Abstract][Full Text] [Related]
11. KDR polymorphism (1192G/A, 1719A/T) and modulation of ARV drug-induced hepatotoxicity.
Singh H; Samani D; Jadhav S
Microb Pathog; 2021 Dec; 161(Pt A):105243. PubMed ID: 34656700
[TBL] [Abstract][Full Text] [Related]
12. IL-10 Promoter -592 Polymorphism may Influence Susceptibility to HIV Infection in South Indian Population.
Harishankar M; Ravikrishnan H; Ravishankar A; Hanna LE; Swaminathan S; Selvaraj P; Bethunaickan R
Curr HIV Res; 2018; 16(1):58-63. PubMed ID: 29468971
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
Giacomelli A; Riva A; Falvella FS; Oreni ML; Cattaneo D; Cheli S; Renisi G; Di Cristo V; Lupo A; Clementi E; Rusconi S; Galli M; Ridolfo AL
BMC Infect Dis; 2018 Nov; 18(1):556. PubMed ID: 30419834
[TBL] [Abstract][Full Text] [Related]
14. ABCG2 polymorphisms and susceptibility to ARV-associated hepatotoxicity.
Singh H; Dhotre K; Shyamveer ; Choudhari R; Verma A; Mahajan SD; Ali N
Mol Genet Genomic Med; 2024 Mar; 12(3):e2362. PubMed ID: 38451012
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of MMP-8 gene polymorphisms in HIV-infected individuals and its association with HIV-associated neurocognitive disorder.
Singh H; Samani D; Nambiar N; Ghate MV; Gangakhedkar RR
Gene; 2018 Mar; 646():83-90. PubMed ID: 29292194
[TBL] [Abstract][Full Text] [Related]
16. Tissue Inhibitor of Metalloproteinase-2 Polymorphisms and Risk for HIV-Associated Neurocognitive Disorder.
Singh H; Jadhav S; Samani D; Nain S
Mediators Inflamm; 2019; 2019():8278095. PubMed ID: 31275061
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of APOBEC3G variations in West Indian HIV patients.
Singh H; Gangakhedkar RR
Microb Pathog; 2018 Aug; 121():325-330. PubMed ID: 29864532
[TBL] [Abstract][Full Text] [Related]
18. Effect of matrix metalloproteinase-21 (572C/T) polymorphism on HIV-associated neurocognitive disorder.
Singh H; Samani D; Nambiar N; Ghate MV; Gangakhedkar RR
APMIS; 2018 Apr; 126(4):329-336. PubMed ID: 29575199
[TBL] [Abstract][Full Text] [Related]
19. Association of cytokine gene polymorphisms in patients with tuberculosis and their household contacts.
Sivangala R; Ponnana M; Thada S; Joshi L; Ansari S; Hussain H; Valluri V; Gaddam S
Scand J Immunol; 2014 Mar; 79(3):197-205. PubMed ID: 24313289
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.
Petros Z; Lee MT; Takahashi A; Zhang Y; Yimer G; Habtewold A; Schuppe-Koistinen I; Mushiroda T; Makonnen E; Kubo M; Aklillu E
OMICS; 2017 Apr; 21(4):207-216. PubMed ID: 28388302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
